N@N

TEL, VRML, GBNK, SH, GUID, OMPI Are Seasonally Ripe To Go Down In the Next Five Weeks

June 27, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of TE CONNECTIVITY LTD (NYSE:TEL), VERMILLION INC (NASDAQ:VRML), GUARANTY BANCORP (NASDAQ:GBNK), PROSHARES SHORT S&P500 (NYSE:SH), GUIDANCE SOFTWARE, INC. (NASDAQ:GUID), Obagi Medical Products Inc (NASDAQ:OMPI) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  TEL     TE CONNECTIVITY LTD              -3.36%           100.00% (5 of 5)     Thursday, July 12th 2012
  VRML    VERMILLION INC                   -27.99%          90.91% (10 of 11)    Tuesday, August 7th 2012
  GBNK    GUARANTY BANCORP                 -5.20%           66.67% (4 of 6)      Thursday, June 28th 2012
  SH      PROSHARES SHORT S&P500           -1.94%           100.00% (6 of 6)     Friday, July 20th 2012
  GUID    GUIDANCE SOFTWARE, INC.          -4.37%           100.00% (5 of 5)     Tuesday, July 10th 2012
  OMPI    Obagi Medical Products Inc       -2.41%           100.00% (5 of 5)     Thursday, June 28th 2012

TE CONNECTIVITY LTD (NYSE:TEL) - TE Connectivity Ltd. provides engineered electronic components, network solutions, specialty products, and subsea telecommunication systems. Its Electronic Components segment supplies passive electronic components, which include connectors and interconnect systems, relays, switches, sensors, and wire and cable to original equipment manufacturers and their contract manufacturers in the automotive, data communications, industrial, appliance, computer, and consumer devices markets. The companys Network Solutions segment supplies infrastructure components and systems for telecommunications and energy markets. This segment provides components comprising connectors, above- and below-ground enclosures, heat shrink tubing, cable accessories, surge arrestors, fiber optic cabling, copper cabling, and racks for copper and fiber networks; electronic systems for test access and intelligent cross-connect applications; and integrated cabling solutions for cabling and building management. This segment also sells insulators, power measurement products, CATV accessories, network interface devices, raceway systems, and duct accessories. Its Specialty Products segment offers engineered custom solutions, components, and connectors for electronic systems, subsystems, and devices in the aerospace, defense, and marine; touch systems; medical; and circuit protection markets. The companys Subsea Communications segment designs, builds, maintains, and tests undersea fiber optic networks for the telecommunications, and oil and gas markets. It sells its products in the Americas, Europe/the Middle East/Africa, and the Asia-Pacific. The company was formerly known as Tyco Electronics Ltd. and changed its name to TE Connectivity Ltd. on March 9, 2011. TE Connectivity Ltd. was founded in 1941 and is based in Schaffhausen, Switzerland.

VERMILLION INC (NASDAQ:VRML) - Vermillion, Inc. and its subsidiaries engage in the discovery, development, and commercialization of diagnostics tests that help physicians to diagnose and treat patients. The company develops novel diagnostic tests in the fields of oncology, hematology, cardiology, and womens health with the initial focus on ovarian cancer. Its lead product includes the OVA1 ovarian tumor triage test (the OVA1 Test), which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. The company has collaborations with various academic and research institutions, including The Johns Hopkins University School of Medicine; The University of Texas M.D. Anderson Cancer Center; University College London; The University of Texas Medical Branch; The Katholieke Universiteit Leuven; Clinic of Gynecology and Clinic of Oncology, Rigshospitalet; Copenhagen University Hospital; The Ohio State University Research Foundation; Stanford University; and the University of Kentucky. It also has strategic alliance agreement with Quest Diagnostics Incorporated to develop and commercialize up to three diagnostic tests. Vermillion, Inc. primarily serves clinical reference laboratories. The company was formerly known as Ciphergen Biosystems, Inc. and changed its name to Vermillion, Inc. in August 2007. Vermillion, Inc. was founded in 1993 and is based in Fremont, California.

GUARANTY BANCORP (NASDAQ:GBNK) - Guaranty Bancorp operates as the bank holding company for Guaranty Bank and Trust Company that provides various banking products and services to consumers, and small and medium-sized businesses. It primarily engages in generating deposits and originating loans. The companys deposit products include demand deposits, negotiable order of withdrawal accounts, money market accounts, individual retirement accounts, time deposits, and savings accounts. Its lending portfolio comprises commercial and industrial, commercial real estate, construction, residential real estate, small business administration guaranteed, and agriculture loans, as well as home equity lines and miscellaneous consumer loans, including overdraft and lines-of-credit. The company also provides trust services, including personal trust administration, estate settlement, investment management accounts, and self-directed individual retirement accounts. As of December 31, 2009, it operated 34 branches in Colorado. The company was formerly known as Centennial Bank Holdings, Inc. and changed its name to Guaranty Bancorp in May 2008. Guaranty Bancorp is based in Denver, Colorado.

PROSHARES SHORT S&P500 (NYSE:SH) - SHORT SP500 PROSHRS

GUIDANCE SOFTWARE, INC. (NASDAQ:GUID) - Guidance Software, Inc. develops and provides software solutions for digital investigations primarily in the United States, Europe, the Middle East, Africa, and the Asia/Pacific Rim. The company offers EnCase Enterprise product that enables corporations and government agencies to search, collect, preserve, and analyze data on the servers, desktops, and laptops on their computer network. It also provides EnCase eDiscovery software that automates the search, collection, preservation, and processing of stored information for litigation and compliance purposes; EnCase Forensic software, which is used by law enforcement and government agencies for collecting, preserving, analyzing, and authenticating electronic computer forensic data for use in criminal and civil court proceedings; and EnCase Legal Hold, a Web-based solution to identify and notify custodians for legal preservation, as well as to manage, track, and report on the actual preservation, collection, and processing of electronically stored information. In addition, the company offers EnCase Portable, an automated search and collection solution; and EnCase Cybersecurity, which provides the ability to identify and analyze undiscovered threats, such as polymorphic or metamorphic malware, and other advanced hacking techniques. It serves government agencies and corporations in various industries, such as financial and insurance services, technology, defense contracting, telecom, pharmaceutical, healthcare, manufacturing, and retail. The company sells its products through direct sales representatives and third-party value-added resellers. Guidance Software, Inc. was founded in 1997 and is headquartered in Pasadena, California.

Obagi Medical Products Inc (NASDAQ:OMPI) - Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets topical aesthetic and therapeutic prescription skin care systems in the United States and internationally. It offers Obagi Nu-Derm System, which includes prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo-damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems that are used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System, a combination of prescription, OTC drugs, and adjunctive cosmetic skin care products to treat skin conditions resulting from sun damage and the oxidative damage of free radicals; and Obagi Professional-C products, a line of proprietary, non-prescription products, which consist of vitamin C serums used to reduce the appearance of damage to the skin caused by ultraviolet radiation and other environmental influences. The company also provides ELASTIderm Eye and Decolletage, which increase the elasticity and skin tone of eyes, face, neckline, and chest; CLENZIderm M.D. Systems used for the treatment of acne; Obagi Rosaclear System used for the treatment of rosacea; Tretinoin used for the treatment of acne; Refissa used for the treatment of fine facial lines, hyperpigmentation, and tactile roughness; Metronidazole, an antibiotic used for the treatment of rosacea in the United States; and Obagi Blue Peel System used for the treatment of fine lines, wrinkles, and hyperpigmentation. In addition, it licenses certain non-prescription product concepts to Japanese based pharmaceutical companies for sale in Japan under the Obagi trademark. Obagi Medical Products, Inc. sells its products through own domestic sales force and foreign distributors to dermatologists, plastic surgeons, and other physicians that are focused on aesthetic and therapeutic skin care. The company was founded in 1988 and is headquartered in Long Beach, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641